METASTATIC MALIGNANT NEOPLASM IN THE BONE
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE BONE trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo targets bone metastases in advanced kidney cancer
Disease control OngoingThis study tests whether adding a radioactive drug (radium-223) to the standard treatment (cabozantinib) can improve outcomes for people with advanced kidney cancer that has spread to the bone. About 134 participants will receive either the combination or cabozantinib alone. The …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Smart scans may boost radiation success in advanced prostate cancer
Disease control OngoingThis study tests whether a special scan called PSMA PET can help pick men with castration-resistant prostate cancer that has spread to the bones who will get the most benefit from Ra-223 radiation therapy. Ra-223 is a radioactive drug that targets bone tumors. The trial enrolled …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Radioactive bullets target bone tumors in breast cancer trial
Disease control OngoingThis study tests a combination of a radioactive drug (radium-223) and chemotherapy (paclitaxel) in 70 people with advanced breast cancer that has spread to the bones. The radioactive drug acts like calcium and collects in bone tumors to kill cancer cells and ease pain. The goal i…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New combo attack on returning prostate cancer shows promise
Disease control OngoingThis study tests whether combining surgery and radiation can help men whose prostate cancer has returned and spread to a few spots in the body. Twenty participants will receive targeted treatments to remove or destroy these cancer spots. The main goal is to see if this approach c…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a shot of radiation stop bone fractures before they start?
Disease control OngoingThis study tests whether giving radiation therapy to high-risk but painless bone tumors can prevent future fractures, spinal cord pressure, or the need for surgery. About 280 cancer patients with multiple metastases will receive either usual care (like bone-strengthening drugs or…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a targeted drug boost chemo for aggressive bone cancer?
Disease control OngoingThis study tests whether adding a drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves how long the cancer stays away. This is a phase 3 stud…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New combo therapy shows promise in advanced kidney cancer trial
Disease control OngoingThis phase 3 trial tests whether adding the targeted therapy cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with untreated, metastatic clear cell renal cell carcinoma are participating. Th…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 08, 2026 12:03 UTC